CARLOS SANTIAGO BOTERO SUAREZ
Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism COLUMBIA, SC NPI 1720547896
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism SC Xeris Pharmaceuticals, Inc. All categories
General Payments — all program years on this page
$171.91
- Category: General Payments
- Program years: PY2024
- Record count: 8
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $171.91 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $171.91 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Xeris Pharmaceuticals, Inc. | $71.81 | 3 |
| Abbott Laboratories | $24.32 | 1 |
| SANOFI-AVENTIS U.S. LLC | $22.34 | 1 |
| ABBVIE INC. | $22.29 | 1 |
| Corcept Therapeutics | $17.19 | 1 |
| Lilly USA, LLC | $13.96 | 1 |
By program year
| Program year | Amount | Records |
|---|---|---|
| 2024 | $171.91 | 8 |
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1103352092 | ABBVIE INC. | $22.29 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1117788741 | Corcept Therapeutics | $17.19 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1125219846 | Abbott Laboratories | $24.32 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1136086166 | Lilly USA, LLC | $13.96 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1139632899 | SANOFI-AVENTIS U.S. LLC | $22.34 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1144589684 | Xeris Pharmaceuticals, Inc. | $23.79 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1144589686 | Xeris Pharmaceuticals, Inc. | $24.01 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1144589688 | Xeris Pharmaceuticals, Inc. | $24.01 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.